Compare Cardinal Health Inc (CAH) vs SPDR Gold Trust (GLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs SPDR Gold Trust — how do they compare? Cardinal Health Inc trades at $228.2 (market cap $53.89B), while SPDR Gold Trust trades at $372.58. The key difference: Cardinal Health Inc pays a 0.89% dividend while SPDR Gold Trust pays none, and Cardinal Health Inc is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals.
| CAH | GLD | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | — |
52-Week High | $239.71 | $495.90 |
52-Week Low | $146.04 | $300.96 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
GLD trades at $367.13, down 2.59% amid a bearish technical setup with 19 sell signals versus 2 buys. Support lies at $365 and $363, while resistance is at $370 and $374. Recent news highlights gold's volatility from inflation data and Fed policy shifts, with prices testing key levels after softer CPI provided temporary relief.
The outlook remains cautious as rising yields and dollar strength pressure gold. Near-term direction hinges on Fed rate expectations and geopolitical tensions. Risks include prolonged high rates eroding gold's appeal, while potential inflation spikes or market instability could renew safe-haven demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →
